Neurogene
NGNE
NGNE
50 hedge funds and large institutions have $302M invested in Neurogene in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
-2
Holders Change %
-3.85%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
21
Reduced
12
Closed
9
Calls
$2.33M
Puts
$4.24M
Net Calls
-$1.91M
Net Calls Change
-$1.99M
Top Buyers
| 1 |
BC
Boxer Capital
San Diego,
California
|
$10.5M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$52.6M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
$7.04M |
| 4 |
Morgan Stanley
New York
|
$1.25M |
| 5 |
MWNA
Marshall Wace North America
New York
|
$806K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
51
Ascend Capital
Orinda,
California
| – | -$2.54M | -10,810 | Closed |
|
52
Renaissance Technologies
New York
| – | -$355K | -1,508 | Closed |
|
|
PP
53
Paloma Partners
Greenwich,
Connecticut
| – | -$304K | -1,291 | Closed |
|
|
TEE
54
Tibra Equities Europe
London,
United Kingdom
| – | -$266K | -1,131 | Closed |
|
55
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$257K | -1,094 | Closed |
|
56
Citadel Advisors
Miami,
Florida
| – | -$125K | -533 | Closed |
|
|
TRCT
57
Tower Research Capital (TRC)
New York
| – | -$11K | -48 | Closed |
|
58
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$7K | -30 | Closed |
|
59
Bank of America
Charlotte,
North Carolina
| – | -$5K | -19 | Closed |
|